Logo - International Journal of Pharmaceutical Compounding

Taurine for the Treatment of Canine Dilated Cardiomyopathy

Author(s):  Vail Jane

Issue:  Nov/Dec 2006 - Veterinary Compounding
View All Articles in Issue

Abstract:  In dogs, dilated cardiomyopathy is a common cardiac disease that is associated with treatment failure, a progressively compromised quality of life, and eventual death from heart failure. Cardiomyopathy in companion animals is treated with a variety of drugs manufactured for the management of cardiac dysfunction in humans, but often those agents do not produce a significantly beneficial response in veterinary patients. In this article, Laura Ivan, DVM, presents her personal experience with the use of a compounded form of the amino acid taurine in the treatment of her Doberman pinscher, whose dilated cardiomyopathy was characteristically sudden in onset. Robert Borger, RPh, a specialist in veterinary compounding, comments on the preparation of taurine for use in dogs with dilated cardiomyopathy.

Related Keywords: Jane Vail, dogs, dilated cardiomyopathy, heart disorders, cardiac disorders, congestive heart failure, taurine, amino acids, veterinary

Related Categories: NUTRITION AND NUTRICEUTICALS, VETERINARY, CARDIOLOGY, DOSAGE FORMS/DRUG CARRIERS

Purchase this article for download in electronic PDF format from IJPC at for $35 at:
http://www.ijpc.com/Products/ProductAddToCart.cfm?PID=2492

Search the entire IJPC archive by keyword, topic, or issue at:
http://ijpc.com/Products